Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Associate Director, Product Management
Brisbane, California · Posted on May 28, 2025
Automation Engineer III
Brisbane, California · Posted on May 28, 2025
Automation Service Engineer III
Brisbane, California · Posted on May 28, 2025
Computational Biologist I
Brisbane, California · Posted on May 28, 2025
Director, HRBP
Brisbane, California · Posted on May 28, 2025
Future Consideration
Brisbane, California · Posted on May 28, 2025
Manager, Accounting
Brisbane, California · Posted on May 28, 2025
Manager, Cost Accounting
Brisbane, California · Posted on May 28, 2025
Senior Computational Biologist
Brisbane, California · Posted on May 28, 2025
Senior Director, Market Access
Brisbane, California · Posted on May 28, 2025
Senior Information Security Analyst II
Remote · Posted on May 28, 2025
Senior Machine Learning Scientist
Brisbane, California · Posted on May 28, 2025
Explore similar companies to Freenome
Eternal
Longevity care for athletes.
Anterior
Lead your health plan into the future.
Tennr
The intelligent automation platform for healthcare ops.
OpenEvidence
The leading medical information platform.
Collate
Empowering life sciences development.
Optura
AI orchestration platform for healthcare.
Plenful
AI workflow platform for healthcare.
Thatch
Modern health benefits platform.
ClarityCare AI
Streamlining health insurance prior authorization.